Clinical and Experimental Vaccine Research

  • 제13권1호
  • /
  • Pages.54-62
  • /
  • 2024
  • /
  • 2287-3651(pISSN)
  • /
  • 2287-366X(eISSN)
대한백신학회 (The Korean Vaccine Society)
권호 표지
DOI QR코드

DOI QR Code

Monitoring and evaluation of provincial classical swine fever immunization implementation with an E2 subunit vaccine in Jeju Island, South Korea

  • Guehwan Jang (College of Veterinary Medicine and Virus Vaccine Research Center, Gyeongsang National University) ;
  • Eun-Joo Kim (Animal Health Division, Jeju Special Self-Governing Province) ;
  • Seong-Cheol Cho (Animal Health Division, Jeju Special Self-Governing Province) ;
  • Sung-Up Moon (Animal Health Division, Jeju Special Self-Governing Province) ;
  • Myeong Hwa Lee (Veterinary Research Institute, Jeju Special Self-Governing Province) ;
  • Jin A Ko (Veterinary Research Institute, Jeju Special Self-Governing Province) ;
  • Seung Bo Ko (Veterinary Research Institute, Jeju Special Self-Governing Province) ;
  • Jonghoo Lee (Veterinary Research Institute, Jeju Special Self-Governing Province) ;
  • Changhee Lee (College of Veterinary Medicine and Virus Vaccine Research Center, Gyeongsang National University)
  • 투고 : 2023.12.19
  • 심사 : 2023.12.27
  • 발행 : 2024.01.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: Accidental vaccination with a live attenuated low-virulence strain of Miyagi (LOM) vaccine led to the reemergence of classical swine fever virus (CSFV) in Jeju province, South Korea in 2014. To control the continual outbreaks of LOM-derived CSFV, the provincial government launched a provincial mass vaccination project using a CSF-E2 subunit vaccine. We conducted this study to assess the herd immunity level and outcomes of E2 vaccine-based immunization in breeding and growing herds on Jeju Island during 2020-2021. Materials and Methods: A large-scale vaccination trial using the Bayovac CSF-E2 vaccine investigated its efficacy in breeding and growing herds under farm application conditions (10 CSFV-affected and three CSFV-naïve swine farms). Results: The level of herd immunity in each farm was classified into three (S1-S3) and six (G1-G6) profiles in breeding and growing herds, respectively. Immunity monitoring revealed a remarkable improvement in the herd immunity status in all farms. The majority (10/13) of farms, including CSFV-free farms, showed the S1G1 immunity profile in 2021, indicating the appropriate implementation of the advised vaccination regime. Moreover, there were significant decreases in Erns seropositivity from 100% to 50% and 25.9% to 4.3% at farm and pig levels, respectively. In particular, all farms were confirmed as CSFV free in the growing-finishing herds. Conclusion: Our large-scale trial demonstrated the effectiveness of the E2 subunit vaccine in establishing herd immunity stabilization and eliminating CSFV circulation in the affected farms and highlighted the need for a provincial vaccination policy to regain the CSF-free status on Jeju Island.

키워드

과제정보

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIT) (No., RS-2023-00251145).

참고문헌

  1. Coronado L, Perera CL, Rios L, Frias MT, Perez LJ. A critical review about different vaccines against classical swine fever virus and their repercussions in endemic regions. Vaccines (Basel) 2021;9:154.
  2. Ganges L, Crooke HR, Bohorquez JA, et al. Classical swine fever virus: the past, present and future. Virus Res 2020;289:198151.
  3. Postel A, Meyer D, Petrov A, Becher P. Recent emergence of a novel porcine pestivirus: interference with classical swine fever diagnosis? Emerg Microbes Infect 2017;6:e19.
  4. Smith DB, Meyers G, Bukh J, et al. Proposed revision to the taxonomy of the genus Pestivirus, family Flaviviridae. J Gen Virol 2017;98:2106-12.
  5. Blome S, Staubach C, Henke J, Carlson J, Beer M. Classical swine fever: an updated review. Viruses 2017;9:86.
  6. Ji W, Guo Z, Ding NZ, He CQ. Studying classical swine fever virus: making the best of a bad virus. Virus Res 2015;197:35-47.
  7. Tautz N, Tews BA, Meyers G. The molecular biology of pestiviruses. Adv Virus Res 2015;93:47-160.
  8. Paton DJ, McGoldrick A, Greiser-Wilke I, et al. Genetic typing of classical swine fever virus. Vet Microbiol 2000;73:137-57.
  9. Postel A, Schmeiser S, Perera CL, Rodriguez LJ, Frias-Lepoureau MT, Becher P. Classical swine fever virus isolates from Cuba form a new subgenotype 1.4. Vet Microbiol 2013;161:334-8.
  10. Fan J, Liao Y, Zhang M, et al. Anti-classical swine fever virus strategies. Microorganisms 2021;9:761.
  11. World Organisation for Animal Health. Official disease status: classical swine fever [Internet]. Paris: WOAH; 2021 [cited 2023 Dec 15]. Available from: https://www.woah.org/en/disease/classical-swine-fever
  12. Postel A, Austermann-Busch S, Petrov A, Moennig V, Becher P. Epidemiology, diagnosis and control of classical swine fever: recent developments and future challenges. Transbound Emerg Dis 2018;65 Suppl 1:248-61.
  13. Wei Q, Liu Y, Zhang G. Research progress and challenges in vaccine development against classical swine fever virus. Viruses 2021;13:445.
  14. Kim B, Song JY, Tark DS, et al. Feed contaminated with classical swine fever vaccine virus (LOM strain) can induce antibodies to the virus in pigs. Vet Rec 2008;162:12-7.
  15. Song JY, Lim SI, Jeoung HY, et al. Prevalence of classical swine fever virus in domestic pigs in South Korea: 1999-2011. Transbound Emerg Dis 2013;60:546-51.
  16. Yoo SJ, Kwon T, Kang K, et al. Genetic evolution of classical swine fever virus under immune environments conditioned by genotype 1-based modified live virus vaccine. Transbound Emerg Dis 2018;65:735-45.
  17. Choe S, Kim JH, Kim KS, et al. Impact of a live attenuated classical swine fever virus introduced to Jeju Island, a CSF-free area. Pathogens 2019;8:251.
  18. Jang G, Kim JA, Kang WM, et al. Endemic outbreaks due to the re-emergence of classical swine fever after accidental introduction of modified live LOM vaccine on Jeju Island, South Korea. Transbound Emerg Dis 2019;66:634-9.
  19. Je SH, Kwon T, Yoo SJ, et al. Classical swine fever outbreak after modified live LOM strain vaccination in naive pigs, South Korea. Emerg Infect Dis 2018;24:798-800.
  20. Jang G, Kim EJ, Cho SC, et al. Field evaluation of the safety and immunogenicity of a classical swine fever virus E2 subunit vaccine in breeding and nursery animals on Jeju Island, South Korea. Clin Exp Vaccine Res 2022;11:264-73.
  21. Jang G, Kim JA, Yoo H, et al. Genomic characterization of classical swine fever virus LOM variants with 3'-UTR INDELs from pigs on Jeju Island, SouthKorea.ArchVirol 2020;165:1691-6.
  22. Hulst MM, Westra DF, Wensvoort G, Moormann RJ. Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera. J Virol 1993;67:5435-42.
  23. Chen JY, Wu CM, Chen ZW, et al. Evaluation of classical swine fever E2 (CSF-E2) subunit vaccine efficacy in the prevention of virus transmission and impact of maternal derived antibody interference in field farm applications. Porcine Health Manag 2021;7:9.
  24. Depner KR, Bouma A, Koenen F, et al. Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows. Vet Microbiol 2001;83:107-20.
  25. de Smit AJ, Bouma A, de Kluijver EP, Terpstra C, Moormann RJ. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination. Vet Microbiol 2001;78:307-17.
  26. Drew T. Classical swine fever (hog cholera). In: Office International des Epizooties, editor. Manual of diagnostic tests and vaccines for terrestrial animals: mammals, birds and bees. 6th ed. Paris: Office International des Epizooties; 2008. p. 1092-106.
  27. Wee SH, Park CK, Jeong JM, et al. Outbreaks of classical swine fever in the Republic of Korea in 2003. Vet Rec 2005;157:113-5.